Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Proton Therapy Market 2022
Proton therapy, also called proton beam therapy, is a type of radiation therapy. Instead of using x-rays like regular radiation treatment, it uses protons to sends beams of high energy that can target tumors more precisely than X-ray radiation. The global proton therapy market is set to increase by US$ 1,029.8 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 13.1% during the forecast period.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for proton therapy. The global proton therapy market is segmented on the basis of component, system type, application, end user, and region. On the basis of component, the global proton therapy market has been segmented into accelerators, beam delivery systems, services, software. The beam delivery systems segment is estimated to account for the largest share of the global proton therapy market. By system type, the global proton therapy market has been segmented into single room systems, multi room systems. The multi room systems segment held the largest revenue share in 2021. Based on application, the global proton therapy market is categorized into breast cancer, lung cancer, pediatric cancer, prostate cancer, skull base cancer, others. Globally, the pediatric cancer segment made up the largest share of the proton therapy market. On the basis of end user, the global proton therapy market has been segmented into proton therapy centers, hospitals, others. In terms of geography, the global proton therapy market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).
The global proton therapy market is highly competitive. Some of the leading companies operating in the market are Hitachi Ltd., IBA (Ion Beam Applications SA), Koninklijke Philips N.V., Mevion Medical Systems Inc., RaySearch Laboratories AB, Sumitomo Heavy Industries Ltd (SHI), Varian Medical Systems Inc.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the proton therapy market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Component: accelerators, beam delivery systems, services, software
System type: single room systems, multi room systems
Application: breast cancer, lung cancer, pediatric cancer, prostate cancer, skull base cancer, others
End user: proton therapy centers, hospitals, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Key Benefits for Stakeholders
– Get a comprehensive picture of the global proton therapy market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Proton therapy market overview
Part 3. Market breakdown by component
– Beam delivery systems
Part 4. Market breakdown by system type
– Single room systems
– Multi room systems
Part 5. Market breakdown by application
– Breast cancer
– Lung cancer
– Pediatric cancer
– Prostate cancer
– Skull base cancer
Part 6. Market breakdown by end user
– Proton therapy centers
Part 7. Market breakdown by region
– Asia Pacific
– North America
– Rest of the World (RoW)
Part 8. Key companies
– Hitachi, Ltd.
– IBA (Ion Beam Applications SA)
– Koninklijke Philips N.V.
– Mevion Medical Systems, Inc.
– RaySearch Laboratories AB
– Sumitomo Heavy Industries, Ltd (SHI)
– Varian Medical Systems, Inc.